Clinical Trial Update: RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

View source ↗

Summary

The trial update reports that the RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care trial sponsored by Response Biomedical Corp. has completed, evaluati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• RAMP 200

Snippet

Sponsor: Response Biomedical Corp. | Conditions: Acute Coronary Syndrome, Myocardial Infarction | Status: COMPLETED